16 April 2024

Fruitful collaboration between patients and clinicians to produce Patient Journeys

We are delighted to share the inspiring journeys of courageous people living with neuromuscular disease. Their stories are a testament to the resilience, strength and power of community support. A innovative collaboration between patients and clinicians aimed at producing insightful Patient Journeys focused on three pathologies: Myasthenia Gravis, Myofibrillar Myopathy, and Multifocal Motor Neuropathy. This innovative initiative seeks to shed light on the unique experiences, challenges, and triumphs of individuals living with these conditions.

👥 Who We Are:

This collaboration brings together a diverse group of individuals, including patients, caregivers, clinicians, and researchers, united by a shared commitment to improving understanding and support for those affected by Myasthenia Gravis, Myofibrillar Myopathy, and Multifocal Motor Neuropathy.

💡 The Vision:

Our vision is to create authentic and informative Patient Journeys that offer valuable insights into the lived experiences of individuals grappling with these complex pathologies. By capturing firsthand accounts, medical perspectives, and collaborative insights, we aim to empower patients, educate clinicians, and foster greater empathy and understanding within the broader community.

🌐 What to Expect:

Through this collaboration, we will embark on a journey of exploration, compassion, and discovery. Over the past few months, we’ve worked closely with patients and clinicians to develop compelling stories that highlight the multifaceted nature of Myasthenia Gravis, Myofibrillar Myopathy, and Multifocal Motor Neuropathy.


This announcement celebrates the collaborative effort between patients and clinicians to produce Patient Journeys focused on Myasthenia Gravis, Myofibrillar Myopathy, and Multifocal Motor Neuropathy, emphasizing the importance of empathy, understanding, and shared experiences in healthcare.

Each Patient Journey will offer a unique perspective, delving into the diagnosis process, treatment strategies, daily challenges, milestones, and moments of resilience and hope. These narratives will serve as invaluable resources for patients seeking support, clinicians striving for greater insight, and researchers pursuing innovative solutions.


The Patient Journeys

Myasthenia Gravis

Download the Patient Journey focused on Myasthenia Gravis in EN


Myofibrillar Myopathy

More details about this Patient Journey here!

Download the Patient Journey focused on Myofibrillar Myopathy in EN


Multifocal Motor Neuropathy

Download the Patient Journey focused on Multifocal Motor Neuropathy in EN

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern